Email updates

Keep up to date with the latest news and content from BMC Nephrology and BioMed Central.

Open Access Highly Accessed Research article

Prevalence of chronic kidney disease in patients with type 2 diabetes in Spain: PERCEDIME2 study

Antonio Rodriguez-Poncelas12, Josep Garre-Olmo2, Josep Franch-Nadal34, Javier Diez-Espino5, Xavier Mundet-Tuduri46, Joan Barrot-De la Puente7, Gabriel Coll-de Tuero12* and RedGDPS Study Group

Author Affiliations

1 EAP Anglès, Girona, Spain

2 Unitat de Recerca IAS, Salt, Spain

3 EAP Raval Sud, Barcelona, Spain

4 Unitat de Recerca Jordi Gol, Barcelona, Spain

5 EAP Tafalla, Navarra, Spain

6 EAP El Carmel, Barcelona, Spain

7 EAP Salt, Girona, Spain

For all author emails, please log on.

BMC Nephrology 2013, 14:46  doi:10.1186/1471-2369-14-46

Published: 22 February 2013



The objective of this study was to determinate the prevalence of chronic kidney disease (CKD) and the different stages of CKD in patients with type 2 diabetes mellitus (DM2) treated in primary care consults in Spain.


A national cross-sectional study was performed in primary care consults. The following data were collected: demographic and anthropometric information; list of present cardiovascular risk factors (CVRF); previous macrovascular and microvascular disease history; physical examination and analytical data from the previous 12 months, including the urine albumin-creatinine ratio (UACR) and estimated glomerular filtration rate (eGFR) to evaluate renal function.


With regard to the patients, 27.9% presented some degree of CKD as follows: 3.5% with stage 1; 6.4% with stage 2; 16.8% with stage 3 (11.6% with stage 3A and 5.2% with stage 3B); and 1.2% with stages 4 and 5. The prevalence of patients with UACR ≥ 30 mg/g was 15.4% (13% microalbuminuria and 2.4% macroalbuminuria). Renal impairment (RI) was found in 206 patients (18%) of whom 133 patients (64.6%) was stage 3A, 60 patients (29.1%) was stage 3B and 13 patients (6.3%) stages 4 and 5. Among patients with RI, 143 patients (69.4%) had normoalbuminuria.

The following variables were significantly associated with CKD: age; sex (women); systolic arterial blood pressure (SABP) ≥ 150 mmHg; and a previous history of cardiovascular disease.


The results showed that the prevalence for any type of CKD was 27.9%. A systematic determination of UACR and eGFR may contribute to an early diagnosis, thus allowing intervention during the initial stages of the disease when treatment is more efficient.

Cross-sectional study; Chronic kidney disease; Renal impairment; Albuminuria; Type 2 diabetes mellitus